Ann: Antimicrobial Data Published in Peer-Reviewed Journal, page-62

You really don't understand what has been published today. The 'market' would not agree that the article is an 'opinion' as it is peer reviewed (e.g. review by other independant scientists to a very high standard) and published by the MOST respected scientific publishing group... it is as close to fact as can be.

I would think the market's reaction wouldn't be massive today as the article itself doesn't necessarily show a clear path to commercialisation. It shows that the product works. What we need to see if phase 2 trial results accepted and move to phase three. That will be the announcement that moves the SP.